Patent Assignment
Reel/Frame 035190/0139
Assignment of Assignor's Interest
Recorded: 2015-03-18
Pages: 7
Assignor
CORRIDOR PHARMACEUTICALS, INC.
Executed: 2014-10-22
Assignee
ASTRAZENECA UK LIMITED
2 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM
Covered Property
(1)
Arginase Inhibitors and Methods of Use
Application:
12/693,863 →
Publication:
US 2010/0189644
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Oct 26, 2011
From: IMMUNE CONTROL INC.; ARGINETIX, INC.
To: CORRIDOR PHARMACEUTICALS, INC.
Reel/Frame 027121/0692 →
Assignment of Assignor's Interest
Oct 7, 2014
From: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA; CORRIDOR PHARMACEUTICALS, INC.
Reel/Frame 033903/0012 →
Confirmatory License
Oct 16, 2014
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034014/0463 →
Assignment of Assignor's Interest
Mar 18, 2015
From: ASTRAZENECA UK LIMITED
To: ASTRAZENECA AB
Reel/Frame 035222/0710 →
Confirmatory License
Nov 16, 2018
From: THE UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047519/0967 →